Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

18.8%

3 terminated/withdrawn out of 16 trials

Success Rate

72.7%

-13.8% vs industry average

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
6(60.0%)
Phase 3
2(20.0%)
Phase 2
1(10.0%)
Phase 1
1(10.0%)
10Total
N/A(6)
Phase 3(2)
Phase 2(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT05942833Not ApplicableRecruiting

Quality of Life in Acute Complicated and Chronic Recurrent Left-sided Diverticulitis

Role: collaborator

NCT06768541Completed

Subsidence of Short Stem THA With DORR Type C

Role: lead

NCT04610645Completed

Optical Coherence Tomography in Patients With Radiotherapy for Head and Neck Cancer

Role: lead

NCT03188796Phase 3Recruiting

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

Role: collaborator

NCT06815796Not ApplicableActive Not Recruiting

Loop Vs. Anchor Tenodesis of the Long Head of the Biceps Brachii Tendon

Role: lead

NCT06430723Completed

The Impact of Obesity on Short Stem Total Hip Arthroplasty

Role: lead

NCT04591860Not ApplicableNot Yet Recruiting

A Prospective Randomised Multi - Center Trial on the Repair of Large Hiatal Hernias: Absorbable Mesh vs. Pledgeted Sutures vs. Sutures Only

Role: collaborator

NCT06030908Unknown

Outcome After Surgical Reconstruction of the Achilles Tendon Insertion.

Role: lead

NCT04400578Not ApplicableCompleted

TRICIN: Prospective Study on the Efficacy of Single Topical Trichloroacetic Acid (TCA) 85% in the Treatment of Cervical Intraepithelial Neoplasia (CIN 1/2)

Role: lead

NCT04918888Completed

COVID-19 Vaccination in Oncologic Patients

Role: lead

NCT02487849Phase 2Withdrawn

HIPEC After Secondary Cytoreductive Operation in Patients With Platinum-sensitive Recurrence of Ovarian Carcinoma

Role: lead

NCT02492477Phase 1Terminated

TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients

Role: lead

NCT01798212Not ApplicableCompleted

Prospective Trial on the Clinical Feasibility of a New Full Thickness Endoscopic Plication Device for Patients With GERD.

Role: lead

NCT01283763Phase 3Terminated

Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia

Role: collaborator

NCT01961102Completed

OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer

Role: lead

NCT01740011Not ApplicableCompleted

Prospective Randomized Trial on Comparison of Standard- Carbon Dioxide Pressure Pneumoperitoneum Insufflators Versus AirSeal

Role: lead

All 16 trials loaded